Toll Free: 1-888-928-9744

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016

Published: Apr 15, 2016 | Pages: 68 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 6 2 Introduction 7 2.1 Coronary Artery Bypass Graft Surgery Overview 7 3 Products under Development 8 3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8 3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9 3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10 3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11 3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12 3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13 4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies 14 4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 14 4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 16 5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 17 5.1 AdvanSource Biomaterials Corporation Company Overview 17 5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Axcelon Biopolymers Corp. Company Overview 20 5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 20 5.3 CardioPolymers, Inc. Company Overview 21 5.3.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 5.4 CellProthera Company Overview 22 5.4.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22 5.5 Coromedic Ltd. Company Overview 24 5.5.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24 5.6 Cytograft Tissue Engineering, Inc. Company Overview 26 5.6.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 5.7 Elana bv Company Overview 28 5.7.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28 5.8 Endogene Ltd Company Overview 29 5.8.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 29 5.9 Graft-Loc Inc. Company Overview 31 5.9.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.10 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 32 5.10.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 5.11 iiTech BV Company Overview 34 5.11.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34 5.12 Magenta Medical Inc Company Overview 37 5.12.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37 5.13 Miracor Medical Systems GmbH Company Overview 38 5.13.1 Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 38 5.14 Neograft Technologies, Inc. Company Overview 40 5.14.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 5.15 NuVascular Technologies Inc Company Overview 44 5.15.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44 5.16 Prekubator TTO Company Overview 45 5.16.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 45 5.17 Revivicor, Inc. Company Overview 46 5.17.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46 5.18 SeamVad Ltd. Company Overview 47 5.18.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47 5.19 St. Jude Medical, Inc. Company Overview 48 5.19.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 5.20 Tengion, Inc. Company Overview 50 5.20.1 Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50 5.21 The University of Utah Company Overview 51 5.21.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 51 5.22 Tissue Regeneration Technologies, LLC Company Overview 52 5.22.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 52 5.23 University College London Company Overview 54 5.23.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 54 5.24 University of Arizona Company Overview 55 5.24.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 55 5.25 University of California, Los Angeles Company Overview 57 5.25.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 57 6 Coronary Artery Bypass Graft Surgery- Recent Developments 58 6.1 Jan 04, 2016: Cellular Regenerative Therapy Greeted by French Minister of Health 58 6.2 Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer 58 6.3 Aug 27, 2015: Bioheart to Change Name to U.S. Stem Cell, Inc. 59 6.4 Aug 06, 2015: Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results 59 6.5 May 20, 2015: Primary Lesion Treatment Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Deposition in Calcified Peripheral Arteries: Preclinical Data Presented at EuroPCR 2015 61 6.6 May 19, 2015: Cardiovascular Systems Peripheral and Coronary Data Featured at EuroPCR 2015 62 6.7 May 12, 2015: Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results 62 6.8 May 06, 2015: Bioheart Highlights Positive First Quarter Results 64 7 Appendix 65 7.1 Methodology 65 7.2 About GlobalData 67 7.3 Contact Us 68 7.4 Disclaimer 68
List of Tables
Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8 Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9 Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10 Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11 Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12 Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13 Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development 14 Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 16 Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 17 Table 10: CardioPass - Product Status 17 Table 11: CardioPass - Product Description 17 Table 12: AdvanSource Biomaterials Corporation - Ongoing Clinical Trials Overview 18 Table 13: CardioPass - CardioPass - European Clinical Trial 19 Table 14: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 20 Table 15: BNC - PVA Based Vascular Graft - Product Status 20 Table 16: BNC - PVA Based Vascular Graft - Product Description 20 Table 17: CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 Table 18: Plexisyl-AF - Product Status 21 Table 19: Plexisyl-AF - Product Description 21 Table 20: CellProthera Pipeline Products & Ongoing Clinical Trials Overview 22 Table 21: CellProthera Automated Device - Product Status 23 Table 22: CellProthera Automated Device - Product Description 23 Table 23: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24 Table 24: Distal Anastomosis Device - Product Status 24 Table 25: Distal Anastomosis Device - Product Description 24 Table 26: Proximal Anastomosis Device - Product Status 25 Table 27: Proximal Anastomosis Device - Product Description 25 Table 28: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 Table 29: LifeLine TEBV - CABG - Product Status 27 Table 30: LifeLine TEBV - CABG - Product Description 27 Table 31: Elana bv Pipeline Products & Ongoing Clinical Trials Overview 28 Table 32: Artificial Vessel - Product Status 28 Table 33: Artificial Vessel - Product Description 28 Table 34: Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 29 Table 35: Cardio-Vascular Stapling Instrument - Product Status 30 Table 36: Cardio-Vascular Stapling Instrument - Product Description 30 Table 37: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 38: Graft-Loc Device - Product Status 31 Table 39: Graft-Loc Device - Product Description 31 Table 40: H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 41: Vascular Stent - Product Status 33 Table 42: Vascular Stent - Product Description 33 Table 43: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 34 Table 44: S


List of Figures
Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development 8 Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment 9 Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory 10 Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path 11 Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date 12 Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify